News & Updates

Snooze Newz: Volume 10, Issue 3
August 17, 2018

Snooze Newz: Volume 10, Issue 2
May 14, 2018


Snooze Newz: Volume 10, Issue 1
February 28, 2018

Snooze Newz: ASA Supplement Issue
December 12, 2017

Snooze Newz: Volume 9, Issue 4
October 18, 2017

Snooze Newz: Volume 9, Issue 3
June 30, 2017

Snooze Newz: Volume 9, Issue 2
March 20, 2017

Snooze Newz: Volume 9, Issue 1
November 29, 2016

Snooze Newz: Volume 8, Issue 4
August 4, 2016

Snooze Newz: Volume 8, Issue 3
April 29, 2016

Snooze Newz: Volume 7, Issue 2
December 3, 2015

Snooze Newz: Volume 7, Issue 1
August 21, 2015


2019-2020 Monthly Educational Activities and Lecture

MARCH


FEBRUARY

JANUARY

DECEMBER

NOVEMBER

OCTOBER

SEPTEMBER

AUGUST

JULY

JUNE

MAY

APRIL

MARCH

FEBRUARY


Video Spotlight

CBS Sunday Morning News takes a look at the University of Oklahoma Anesthesia Department and their use of the OU College Of Medicine's Clinical Skills Education & Testing Center.
 
CBS Sunday Morning News

OU Medicine News

The Children’s Hospital Physician-Scientist Leads Federal Panel on Neurofibromatosis Research
     
Sanjay Bidichandani

OKLAHOMA CITY – A physician-scientist with The Children’s Hospital at OU Medicine has been elected chair of a federal panel that helps to guide research in neurofibromatosis, one of the more common genetic conditions.
      Sanjay Bidichandani, MBBS, Ph.D., has assumed leadership of a U.S. Department of Defense review panel that determines the trajectory and funding of research into neurofibromatosis, a condition that predisposes people to cancer. The panel is part of the DoD’s Congressionally Directed Medical Research Program in Neurofibromatosis.
      DoD-funded research is typically associated with military-related injuries, such as traumatic brain injury and post-traumatic stress disorder. However, the DoD has a separate arm for research into many diseases and conditions. It awards about $15 million annually for neurofibromatosis.
      “Because neurofibromatosis is a genetic condition and knowing that people can develop malignant tumors because of it, we want to develop effective screening, imaging and surgical techniques, better genetic diagnostic methods, and specific therapies to help people with the condition,” said Bidichandani, chief of the section of Genetics and Children’s Hospital Foundation Claire Gordon Duncan Chair in Genetics in the OU College of Medicine.
      Neurofibromatosis is an autosomal dominant condition – inheriting an abnormal gene from either parent can cause the condition in a child. There are two main types of neurofibromatosis, NF1 and NF2. People with NF1 typically have bumps all over the body called neurofibromas. The bumps themselves are benign, but over time, they carry a risk of malignant transformation – becoming a fairly aggressive cancer. In NF2, the tumors are usually inside the brain, where they affect the nerves that conduct hearing, or can press against other parts of the brain.
      While there is no average age of diagnosis for NF, it is often discovered in children who have an aggressive form of the condition. Only then do parents realize they have bumps that represent the condition, though usually a less serious form. The cause for the wide variability in clinical severity, even among members of the same family, remains largely unexplained, Bidichandani said.
      The Children’s Hospital has a dedicated NF clinic in the OU Children’s Physicians building, where doctors, a physician assistant and genetic counselors care for patients and their relatives.
      “Because NF is a cancer predisposition syndrome, children and adults must be screened on a regular basis,” Bidichandani said. “If their bumps are getting too large or are pressing against something else, they may need to be surgically removed. And certainly we monitor to make sure they aren’t becoming cancerous.”
      In his role with the DoD panel, Bidichandani leads a group that performs the final review of grant applications and allocates the money to researchers across the nation and internationally. He also leads a vision-setting panel in planning the course of research for the future, taking into account new developments in the field and areas where grants can make the most impact toward improved patient care. A portion of the grant portfolio also funds a clinical trials consortium in which several medical centers pool resources to test novel therapies for safety and effectiveness.
 
OU MEDICINE
OU Medicine — along with its academic partner, the University of Oklahoma Health Sciences Center — is the state’s only comprehensive academic health system of hospitals, clinics and centers of excellence. With 11,000 employees and more than 1,300 physicians and advanced practice providers, OU Medicine is home to Oklahoma’s largest physician network with a complete range of specialty care. OU Medicine serves Oklahoma and the region with the state’s only freestanding children’s hospital, the only National Cancer Institute-Designated Stephenson Cancer Center and Oklahoma’s flagship hospital, which serves as the state’s only Level 1 trauma center. OU Medicine is the No. 1 ranked hospital system in Oklahoma, and its oncology program at Stephenson Cancer Center and OU Medical Center ranked in the Top 50 in the nation, in the 2019-2020 rankings released by U.S. News & World Report. OU Medicine’s mission is to lead healthcare in patient care, education and research. To learn more, visit oumedicine.com.

THE CHILDREN’S HOSPITAL 
At The Children’s Hospital, pediatric staff blends years of training with education, research and technology to improve the lives of children throughout the region. The obstetric emergency room at The Children’s Hospital is a regional referral center for the state, and the neonatal intensive care unit provides the highest level of newborn care in Oklahoma. Children’s is also home to the only 24/7 pediatric emergency room in Oklahoma City. With a family-centered approach to healing, Children’s offers resources from pet therapy to child life specialists who help families cope with hospitalization and illness. From advanced surgical services to general pediatrics, oncology care and more, The Children’s Hospital provides cutting-edge research and treatments through hospital-based and outpatient services. To learn more, visit oumedicine.com/childrens.